We also found that underlying diseases (diabetes and hypertension), initial clinical characteristics (cough, expectoration, dyspnea, asthma, and debilitation), and laboratory findings [LYMR ALT, AST, CK, GlU, and procalcitonin (PCT)] were also significantly associated with disease progression, although these were non-specific. This evidence concerns the gene GPT and Hypertension.